The drug, icotrokinra, was tested in patients with plaque psoriasis, a skin condition that causes dry and itchy patches on the skin. In the trial, the drug showed significant skin clearance in 64.7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback